author-photo

Pat Watson

Janssen Pharmaceutica

4

Papers

37

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

P3.04-008 A Phase 1b/2 Study of Atezolizumab With or Without Daratumumab in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
KEYNOTE-240: Randomized phase III study of pembrolizumab versus best supportive care for second-line advanced hepatocellular carcinoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (29)
Randomized, open-label phase Ib/II study of atezolizumab with or without daratumumab in previously treated advanced or metastatic non-small cell lung cancer (NSCLC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)